The study indicates that in DM/PM patients, the high expression of NLRP3 inflammasomes in muscle tissues activates caspase-1 expression, leading to upregulation of IL-1β and IL-18 levels, enhancing cellular immunity. The gene discussed is NLRP3; the disease is dermatomyositis.